The trademark application PHYDUXON was filed by FULLHOPE BIOMEDICAL CO., LTD., a corporation established under the laws of Taiwan, Republic of China (the "Applicant"). The application was published for oppositions on September 16, 2020, and it was registered by office on December 25, 2020 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Vaccines for human use
Immunostimulants
Pre-filled syringes for medical purposes
Anti-cancer drugs
Medicines for human purposes
Diagnostic agents for medical use
Biological preparations for medical purposes
Blood for medical purposes
Vaccines
Adjuvants for medical purposes
Albuminous preparations for medical purposes
Pharmaceutical drugs
Pharmaceutical preparations
Diagnostic preparations for medical purposes
Diagnostic biomarker reagents for medical purposes
Stem Cells for medical purposes
Immunomodulators
Pharmaceutical preparations for the treatment of immune system related diseases and disorders
Reagents for in-vitro laboratory use [for medical purposes]